Research Projects & Grants

Federal

• FHCRC - 1630.00 - a multi-center pilot study of high-dose immunoablative therapy using cyclophosphamide and anti-thymocyte globulin and followed by autologous or syngeneic peripheral blood stem cell transplantation for patients with refractory systemic lupus erythematosus, Role: Investigator, National Institutes of Health/DHHS, (05/2003 - 05/2004) Status: Completed